CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | Knowles Julius Director | Sale | −2,350 | $59.08 | $139K | 623,847 |
| 2021-04-01 | Knowles Julius Director | Sale | −1,533 | $59.08 | $91K | 416,820 |
| 2021-04-01 | Knowles Julius Director | Sale | −434 | $60.82 | $26K | 623,413 |
| 2021-04-01 | Knowles Julius Director | Sale | −283 | $60.82 | $17K | 416,537 |
| 2021-04-01 | Knowles Julius Director | Sale | −206 | $61.36 | $13K | 623,207 |
| 2021-04-01 | Knowles Julius Director | Sale | −134 | $61.36 | $8K | 416,403 |
| 2021-04-01 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +9,996 | $0.11 | $1K | 71,187 |
| 2021-04-01 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −9,996 | 0 | ||
| 2021-03-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion | +1,000 | $0.48 | $480 | 1,000 |
| 2021-03-11 | Ordonez Claudia Chief Medical Officer | Sale | −395 | $64.09 | $25K | 605 |
| 2021-03-11 | Ordonez Claudia Chief Medical Officer | Sale | −605 | $64.86 | $39K | 0 |
| 2021-03-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 101,211 | ||
| 2021-03-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 66,491 |
| 2021-03-11 | Lachey Jennifer Chief Scientific Officer | Sale | −1,739 | $63.99 | $111K | 64,752 |
| 2021-03-11 | Lachey Jennifer Chief Scientific Officer | Sale | −3,557 | $64.72 | $230K | 61,195 |
| 2021-03-11 | Lachey Jennifer Chief Scientific Officer | Sale | −4 | $65.47 | $262 | 61,191 |
| 2021-03-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 140,305 | ||
| 2021-03-04 | Knowles Julius Director | Sale | −1,662 | $54.22 | $90K | 635,365 |
| 2021-03-04 | Knowles Julius Director | Sale | −1,086 | $54.22 | $59K | 424,331 |
| 2021-03-04 | Knowles Julius Director | Sale | −2,962 | $55.21 | $164K | 632,403 |
Page 23 of 36 · 707 trades